US Stock MarketDetailed Quotes

SOPH Sophia Genetics

Watchlist

3.680
-0.010-0.27%

Close Sep 10 16:00 ET

3.680
0.0000.00%

Post 20:01 ET

243.65MMarket Cap-3607P/E (TTM)

Sophia Genetics Stock Forum

Jaguar8

May 29 09:00

NEWS

$Sophia Genetics (SOPH.US)$
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities
SOPHiA GENETICS (Nasdaq: SOPH) announced a collaboration with Microsoft and NVIDIA to launch a whole genome sequencing (WGS) analytical solution by end of 2024. The new WGS application aims to deliver fully analyzed genome insights within the same day, enhancing research, drug discovery, and clinical care. Leveraging Microsoft Azure and NVIDIA Parabricks, the solution will provide scalable and rapid...

Stock_Drift

Apr 17 05:12

I’m in at a 1.00 & a half.🍿⭐️🍿

$Sophia Genetics (SOPH.US)$

Jaguar8

Apr 17 05:06

$Sophia Genetics (SOPH.US)$
NEWS
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
Unilabs, a leading diagnostic provider in Europe, has implemented SOPHiA GENETICS' AI technology for HRD testing in solid tumors across its network in Switzerland. HRD, a common alteration in ovarian cancer, affects approximately half of newly diagnosed patients, making it a important factor in treatment planning. SOPHiA GENETICS' SOPHiA DDM™ Platform u...

Jaguar8

Apr 4 00:14

$Sophia Genetics (SOPH.US)$ NEWS:
SOPHiA GENETICS (SOPH) partners with Strand Life Sciences to advance precision medicine globally. The collaboration aims to provide innovative solutions leveraging genomics technologies and bioinformatics services.

Moomoo AI

Mar 11 07:21

SOPHiA GENETICS' high P/S ratio is due to its promising revenue outlook. Shareholders' confidence in future revenues is keeping the P/S high. Strong revenue predictions should maintain the share price, unless analysts have missed their forecasts.

Investors Appear Satisfied With SOPHiA GENETICS SA's (NASDAQ:SOPH) Prospects

Moomoo AI

Nov 16, 2023 04:34

SOPHiA GENETICS' high P/S ratio may indicate expected solid revenue growth. Current shareholders are likely okay with the high P/S ratio based on strong earnings forecasts, expecting robust growth to sustain the share price, but investors should also be aware of potential risks.